| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |